TheStreet

Log In

Receive full access to our market insights, commentary, newsletters, breaking news alerts, and more.
Forgot your password?Don't have an account? Sign Up Here

Join Us

Receive full access to our market insights, commentary, newsletters, breaking news alerts, and more.
Already have an account? Login here
TheStreet
JIM CRAMERINVESTINGPERSONAL FINANCERETIREMENTTECHNOLOGYMARKETSHOW-TOVIDEOFINANCIAL ADVISOR CENTER
Search

Trade with Jim Cramer 14 Days Free

Join the Action Alerts PLUS Community today!

SUBSCRIBE NOW

LATEST NEWS

Novartis to Swallow Up The Medicines Company for $9.7 Billion
INVESTING

3 Biotech Stocks I Love for March (Celgene Is One of Them)

  • By Bret Jensen
  • Mar 1, 2018 10:30 PM EST
The Best Part of the Biotech Rally This Year Is Probably Over
VIDEO

The Best Part of the Biotech Rally This Year Is Probably Over

  • By Scott Gamm
  • Sep 15, 2017 4:52 PM EDT
Northern Trust Hits New Highs, New Resistance
STOCKS

5 stocks poised for major breakouts

  • By Roberto Pedone
  • Dec 23, 2016 1:26 PM EST
Valeant Acquires Eyegate Licensing Rights
OPINION

13 companies to watch from MIT's smart 50 list, including 4 buys

  • By Robert Wasserman
  • Jul 21, 2016 7:48 AM EDT
The High Cost Wilbur Ross Would Have to Pay to Join Trump's Cabinet
OPINION

9 Investments Wilbur Ross Is Making That Aren't Greece

  • By Emily Stewart
  • Jul 8, 2015 9:00 AM EDT
5 Hated Earnings Stocks You Should Love
INVESTING

5 Breakout Stock Plays: NQ Mobile, T2 Biosystems and More

  • By Roberto Pedone
  • Nov 25, 2014 10:36 AM EST
TheStreet
  • Terms Of Use
  • Privacy Policy
  • Advertise
  • Reprints
  • Customer Service
  • Data
  • Topic Archive
  • Subscriptions
© 2021 TheStreet, Inc. All rights reserved. Action Alerts PLUS is a registered trademark of TheStreet, Inc.